invasive Meningococcal Infection caused by Neisseria meningitidis serogroup W-135
DBCOND0093732Bacterial Infections
invasive Meningococcal Infection caused by Neisseria meningitidis serogroup W-135 is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.
- Classified under
- Indicated drugs
- Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine
- Meningococcal polysaccharide vaccine group W-135
- Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen
- Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen
What you can answer from here — as of October 27, 2026
4Indicated drugsWith each drug's targets and mechanismListed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for invasive Meningococcal Infection caused by Neisseria meningitidis serogroup W-135 share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account